Elanco Animal Health (ELAN) Updates FY 2019 Earnings Guidance

Share on StockTwits

Elanco Animal Health (NASDAQ:ELAN) updated its FY 2019 earnings guidance on Thursday. The company provided earnings per share guidance of $1.02-1.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.08. The company issued revenue guidance of $3.08-3.14 billion, compared to the consensus revenue estimate of $3.13 billion.

Several research firms have recently commented on ELAN. Zacks Investment Research lowered Elanco Animal Health from a buy rating to a hold rating in a report on Tuesday, March 5th. UBS Group began coverage on Elanco Animal Health in a report on Wednesday, March 20th. They set a sell rating and a $28.00 target price for the company. Bank of America raised Elanco Animal Health from a neutral rating to a buy rating and set a $30.95 target price for the company in a report on Monday, March 18th. William Blair began coverage on Elanco Animal Health in a report on Monday, February 11th. They set a market perform rating and a $29.71 target price for the company. Finally, Argus began coverage on Elanco Animal Health in a report on Tuesday, January 15th. They set a buy rating and a $37.00 target price for the company. One research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. Elanco Animal Health currently has a consensus rating of Hold and a consensus price target of $33.22.

NASDAQ:ELAN opened at $31.39 on Thursday. Elanco Animal Health has a 52 week low of $28.00 and a 52 week high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last posted its earnings results on Wednesday, February 6th. The company reported $0.29 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.03. The company had revenue of $799.30 million for the quarter, compared to the consensus estimate of $804.07 million. During the same period last year, the company posted $0.12 earnings per share. The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year.

In other Elanco Animal Health news, Director R David Hoover acquired 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was acquired at an average cost of $31.43 per share, with a total value of $628,600.00. The transaction was disclosed in a filing with the SEC, which is available through this link.

WARNING: “Elanco Animal Health (ELAN) Updates FY 2019 Earnings Guidance” was originally published by Equities Focus and is the sole property of of Equities Focus. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://www.equitiesfocus.com/2019/05/09/elanco-animal-health-elan-updates-fy-2019-earnings-guidance.html.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Featured Article: Quiet Period

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.